These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 18551048

  • 1. ABO-incompatible living donor liver transplantation: new insights into clinical relevance.
    Kawagishi N, Satomi S.
    Transplantation; 2008 Jun 15; 85(11):1523-5. PubMed ID: 18551048
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study.
    Sanada Y, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, Koinuma T, Koyama K, Tanaka S, Misawa K, Wada M, Nunomiya S, Yasuda Y, Kawarasaki H.
    Ther Apher Dial; 2012 Aug 15; 16(4):368-75. PubMed ID: 22817126
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K.
    Transplant Proc; 2006 Dec 15; 38(10):3629-32. PubMed ID: 17175351
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunosuppression in living donor liver transplantation from ABO blood type incompatible donors].
    Egawa H, Oike F, Tanaka K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec 15; 23(6):636-9. PubMed ID: 11210760
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW, Park YK, Kim YB, Wang HJ, Kim MW.
    Transplant Proc; 2008 Dec 15; 40(10):3772-7. PubMed ID: 19100487
    [Abstract] [Full Text] [Related]

  • 13. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
    Kawagishi N, Takeda I, Miyagi S, Satoh K, Akamatsu Y, Sekiguchi S, Fujimori K, Sato T, Satomi S.
    Ther Apher Dial; 2007 Oct 15; 11(5):319-24. PubMed ID: 17845390
    [Abstract] [Full Text] [Related]

  • 14. The role of ABO-incompatible living donors in kidney transplantation: state of the art.
    Thielke J, Kaplan B, Benedetti E.
    Semin Nephrol; 2007 Jul 15; 27(4):408-13. PubMed ID: 17616273
    [Abstract] [Full Text] [Related]

  • 15. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Yoshizawa A, Sakamoto S, Ogawa K, Kasahara M, Uryuhara K, Oike F, Ueda M, Takada Y, Egawa H, Tanaka K.
    Transplant Proc; 2005 May 15; 37(4):1718-9. PubMed ID: 15919443
    [Abstract] [Full Text] [Related]

  • 16. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N, Iwamoto H, Nakamura Y, Hama K, Kihara Y, Konno O, Jojima Y, Akashi I, Mijiti A, Ashizawa T, Nagao T.
    Transplant Proc; 2008 Oct 15; 40(8):2497-500. PubMed ID: 18929778
    [Abstract] [Full Text] [Related]

  • 17. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
    Nakamura Y, Matsuno N, Iwamoto H, Yokoyama T, Kuzuoka K, Kihara Y, Taira S, Sagara T, Jojima Y, Konno O, Tashiro J, Akashi I, Hama K, Narumi K, Iwahori T, Uchiyama M, Tanaka K, Nagao T.
    Transplant Proc; 2004 Oct 15; 36(8):2269-73. PubMed ID: 15561215
    [Abstract] [Full Text] [Related]

  • 18. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, Oike F, Fukuda A, Yoshizawa J, Takada Y, Tanaka K, Maekawa T, Ozawa K, Uemoto S.
    Liver Transpl; 2007 Apr 15; 13(4):579-88. PubMed ID: 17394164
    [Abstract] [Full Text] [Related]

  • 19. Preapheresis immunosuppressive induction: necessary or harmful?
    Wennberg L, Genberg H, Tydén G.
    Transplantation; 2007 Dec 27; 84(12 Suppl):S37-9. PubMed ID: 18162987
    [Abstract] [Full Text] [Related]

  • 20. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H, Sato Y, Yamamoto S, Nakatsuka H, Kobayashi T, Watanabe T, Hara Y, Kokai H, Hatakeyama K.
    Transplant Proc; 2009 Dec 27; 41(1):222-5. PubMed ID: 19249519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.